ONCSQ — OncoSec Medical Incorporated Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-UnitedHealth, Lifestyle, Exxon
U.S. STOCKS ON THE MOVE-LegalZoom, Snail, metal miners
OncoSec Medical rises on positive data from cancer therapy trial
Brief: Oncosec Announces Positive Clinical Data Of Keynote-695 Trial Assessing Tavo-Ep In Combination With Pembrolizumab
OncoSec Medical slumps on reverse stock split plan
Brief: Oncosec Medical Inc Files For Offering On A "Reasonable Best Efforts" Basis Up To $10 Mln Of Shares Of Common Stock - SEC Filing
Brief: Oncosec Announces Pipeline Prioritization And Workforce Reduction
Brief: Oncosec Medical Says Will Reduce Current Workforce By Approximately 18 Employees
Brief: Oncosec Medical Inc Received Notice From Nasdaq That Co Is Not In Compliance With Minimum Bid Price Listing To List On Nasdaq
Brief: OncoSec Appoints Robert Arch as President and CEO
U.S. RESEARCH ROUNDUP-Avalonbay Communities, Goodrx Holdings, Host Hotels & Resorts
Brief: OncoSec Announces Appointment Of George Chi As Chief Financial Officer
Brief: Oncosec Announces Changes To Board Of Directors
Brief: OncoSec Medical Inc Files For Mixed Shelf Of Upto $100 Mln
Brief: Oncosec Medical Says Effective Immediately, Oncosec's Interim CEO, Mr. Brian Leuthner, Will Be Leaving Company
OncoSec rises on collaboration with Merck & Co to test skin cancer drug
Brief: OncoSec Enters Into Agreement With Merck For Pivotal Global Phase 3 Study, Keynote-C87, Of Tavo Combined With Keytruda
Brief: Oncosec Appoints Brian Leuthner As Interim Chief Executive Officer
Brief: OncoSec Appoints Robert Schinagl As VP Of Program And Alliance Management